Z-0820-2021 Class II Ongoing
FDA device recall Z-0820-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Nov 7, 2020 and is designated Class II. Reason for recall: The sodium and/or calcium levels in these concentrates were below the manufacturing specifications. The recall status is ongoing. Affected quantity: 19646 cases.
Recall details
- Product Type
- Devices
- Report Date
- Jan 20, 2021
- Initiation Date
- Nov 7, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19646 cases
Product description
NaturaLyte Liquid Acid concentrate bottles, Model Number 08-3251-9 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.
Reason for recall
The sodium and/or calcium levels in these concentrates were below the manufacturing specifications.
Distribution pattern
US Nationwide distribution.
Code information
Lot Numbers: 20LXAC043 20LXAC044 20LXAC045 20LXAC059 20LXAC060 20LXAC079 20LXAC095 20NXAC026 Additional lots as of 3/17/21: 20LXAC078 20NXAC012 20LXAC058 20LXAC096 20NXAC011
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0820-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026